Author
Listed:
- Khalid A. Bin Abdulrahman
(Department of Medical Education, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia)
- Abdullah Omar Bamosa
(Department of Physiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia)
- Abdullah I. Bukhari
(Department of Medicine, Division of Infectious Diseases, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317, Saudi Arabia)
- Intisar Ahmad Siddiqui
(Department of Dental Education, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia)
- Mostafa A. Arafa
(Cancer Research Chair, College of Medicine, King Saud University, P.O. Box 2925, Riyadh 11461, Saudi Arabia
Epidemiology Department, High Institute of Public Health, Alexandria University, Alexandria 21561, Egypt)
- Ashfaq A. Mohsin
(Department of Pharmaceutics, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia)
- Mamdouh Faleh Althageel
(Ministry of Health, King Salman Bin Abdulaziz Hospital, Riyadh 12769, Saudi Arabia)
- Majed Owed Aljuaeed
(Ministry of Health, King Salman Bin Abdulaziz Hospital, Riyadh 12769, Saudi Arabia)
- Ibrahim Mohammed Aldeailej
(Ministry of Health, Riyadh Regional Lab and Blood Bank, Riyadh 12746, Saudi Arabia)
- Abdulaziz Ibrahim Alrajeh
(Ministry of Health, Riyadh Regional Lab and Blood Bank, Riyadh 12746, Saudi Arabia)
- Kamel Mohamed Aldosari
(Ministry of Health, Riyadh Regional Lab and Blood Bank, Riyadh 12746, Saudi Arabia)
- Najat Ahmed Hawsawi
(Ministry of Health, Riyadh Regional Lab and Blood Bank, Riyadh 12746, Saudi Arabia)
- Khalid Ibrahim Zawbaee
(Ministry of Health, Riyadh Regional Lab and Blood Bank, Riyadh 12746, Saudi Arabia)
- Saad Mohammed Alsurayea
(Ministry of Health, Riyadh Regional Lab and Blood Bank, Riyadh 12746, Saudi Arabia)
Abstract
The current study investigated the impact of different doses of Nigella sativa seeds on the symptoms, the cluster of differentiation profile group, and inflammatory markers of mild COVID-19 cases. Methods: The study was a double-blind placebo-controlled clinical trial. Patients with mild and asymptomatic SARS-CoV-2 infection patients were randomly subdivided into seven subgroups: Group (GP) 1: received charcoal capsules as a control group, and GP 2: received three capsules of whole Nigella sativa seeds daily, two capsules in the morning and one in the evening; GP 3: received three capsules of whole Nigella sativa seeds every 12 h, GP 4: received five capsules in the morning and four capsules of whole Nigella sativa seeds in the evening, GP 5: received one capsule of Nigella sativa powder every 12 h; GP 6: received two capsules of Nigella sativa powder every 12 h; GP 7: received three capsules of Nigella sativa powder every 12 h; all treatment course was for ten days. Inflammatory parameters were assessed before and after interventions. Results: 262 subjects were included in the final analysis. No significant difference was detected regarding age, gender, and nationality. No significant differences were detected between the inflammatory marker in all groups. The WBCs showed a significant difference between before and after the intervention. While for procalcitonin, a significant difference was demonstrated in groups 1,4, and 6. Conclusions: The current randomized clinical trial did not reveal a significant effect of ten days of treatment with various doses of Nigella sativa on symptoms, differentiation profile, and inflammatory markers of patients with COVID-19. As a natural product, the effect of Nigella sativa on disease requires weeks to manifest itself.
Suggested Citation
Khalid A. Bin Abdulrahman & Abdullah Omar Bamosa & Abdullah I. Bukhari & Intisar Ahmad Siddiqui & Mostafa A. Arafa & Ashfaq A. Mohsin & Mamdouh Faleh Althageel & Majed Owed Aljuaeed & Ibrahim Mohammed, 2022.
"The Effect of Short Treatment with Nigella Sativa on Symptoms, the Cluster of Differentiation (CD) Profile, and Inflammatory Markers in Mild COVID-19 Patients: A Randomized, Double-Blind Controlled Tr,"
IJERPH, MDPI, vol. 19(18), pages 1-14, September.
Handle:
RePEc:gam:jijerp:v:19:y:2022:i:18:p:11798-:d:918582
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:18:p:11798-:d:918582. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.